nodes	percent_of_prediction	percent_of_DWPC	metapath
Cidofovir—Tenofovir—NME2—ovarian cancer	0.0326	1	CrCbGaD
Cidofovir—TYMP—myometrium—ovarian cancer	0.0134	0.145	CbGeAlD
Cidofovir—TYMP—uterine cervix—ovarian cancer	0.0104	0.113	CbGeAlD
Cidofovir—TYMP—decidua—ovarian cancer	0.00993	0.108	CbGeAlD
Cidofovir—TYMP—endometrium—ovarian cancer	0.00943	0.102	CbGeAlD
Cidofovir—TYMP—uterus—ovarian cancer	0.00869	0.0943	CbGeAlD
Cidofovir—TYMP—female reproductive system—ovarian cancer	0.00781	0.0848	CbGeAlD
Cidofovir—TYMP—bone marrow—ovarian cancer	0.00738	0.0801	CbGeAlD
Cidofovir—TYMP—female gonad—ovarian cancer	0.00711	0.0772	CbGeAlD
Cidofovir—TYMP—vagina—ovarian cancer	0.00707	0.0767	CbGeAlD
Cidofovir—TYMP—testis—ovarian cancer	0.0063	0.0684	CbGeAlD
Cidofovir—TYMP—lymph node—ovarian cancer	0.00457	0.0496	CbGeAlD
Cidofovir—Convulsion—Docetaxel—ovarian cancer	0.000453	0.000517	CcSEcCtD
Cidofovir—Paraesthesia—Paclitaxel—ovarian cancer	0.000452	0.000516	CcSEcCtD
Cidofovir—Hypertension—Docetaxel—ovarian cancer	0.000451	0.000516	CcSEcCtD
Cidofovir—Bronchitis—Doxorubicin—ovarian cancer	0.00045	0.000514	CcSEcCtD
Cidofovir—Dyspnoea—Paclitaxel—ovarian cancer	0.000449	0.000513	CcSEcCtD
Cidofovir—Somnolence—Paclitaxel—ovarian cancer	0.000447	0.000511	CcSEcCtD
Cidofovir—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000447	0.000511	CcSEcCtD
Cidofovir—Arthralgia—Docetaxel—ovarian cancer	0.000445	0.000508	CcSEcCtD
Cidofovir—Chest pain—Docetaxel—ovarian cancer	0.000445	0.000508	CcSEcCtD
Cidofovir—Myalgia—Docetaxel—ovarian cancer	0.000445	0.000508	CcSEcCtD
Cidofovir—Pancytopenia—Doxorubicin—ovarian cancer	0.000445	0.000508	CcSEcCtD
Cidofovir—Nausea—Vinorelbine—ovarian cancer	0.000444	0.000508	CcSEcCtD
Cidofovir—Renal failure—Epirubicin—ovarian cancer	0.000444	0.000507	CcSEcCtD
Cidofovir—Dyspepsia—Paclitaxel—ovarian cancer	0.000443	0.000506	CcSEcCtD
Cidofovir—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000442	0.000505	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000442	0.000505	CcSEcCtD
Cidofovir—Jaundice—Epirubicin—ovarian cancer	0.00044	0.000502	CcSEcCtD
Cidofovir—Stomatitis—Epirubicin—ovarian cancer	0.00044	0.000502	CcSEcCtD
Cidofovir—Urinary tract infection—Epirubicin—ovarian cancer	0.000439	0.000501	CcSEcCtD
Cidofovir—Conjunctivitis—Epirubicin—ovarian cancer	0.000439	0.000501	CcSEcCtD
Cidofovir—Dysuria—Doxorubicin—ovarian cancer	0.000438	0.0005	CcSEcCtD
Cidofovir—Neutropenia—Doxorubicin—ovarian cancer	0.000438	0.0005	CcSEcCtD
Cidofovir—Decreased appetite—Paclitaxel—ovarian cancer	0.000438	0.0005	CcSEcCtD
Cidofovir—Dry mouth—Docetaxel—ovarian cancer	0.000435	0.000497	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000435	0.000496	CcSEcCtD
Cidofovir—Sweating—Epirubicin—ovarian cancer	0.000433	0.000494	CcSEcCtD
Cidofovir—Pollakiuria—Doxorubicin—ovarian cancer	0.000433	0.000494	CcSEcCtD
Cidofovir—Pain—Paclitaxel—ovarian cancer	0.00043	0.000492	CcSEcCtD
Cidofovir—Constipation—Paclitaxel—ovarian cancer	0.00043	0.000492	CcSEcCtD
Cidofovir—Haematuria—Epirubicin—ovarian cancer	0.00043	0.000491	CcSEcCtD
Cidofovir—Confusional state—Docetaxel—ovarian cancer	0.00043	0.000491	CcSEcCtD
Cidofovir—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000427	0.000488	CcSEcCtD
Cidofovir—Anaphylactic shock—Docetaxel—ovarian cancer	0.000427	0.000487	CcSEcCtD
Cidofovir—Oedema—Docetaxel—ovarian cancer	0.000427	0.000487	CcSEcCtD
Cidofovir—Weight increased—Doxorubicin—ovarian cancer	0.000426	0.000487	CcSEcCtD
Cidofovir—Epistaxis—Epirubicin—ovarian cancer	0.000426	0.000486	CcSEcCtD
Cidofovir—Infection—Docetaxel—ovarian cancer	0.000424	0.000484	CcSEcCtD
Cidofovir—Weight decreased—Doxorubicin—ovarian cancer	0.000424	0.000484	CcSEcCtD
Cidofovir—Sinusitis—Epirubicin—ovarian cancer	0.000423	0.000484	CcSEcCtD
Cidofovir—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000422	0.000483	CcSEcCtD
Cidofovir—Pneumonia—Doxorubicin—ovarian cancer	0.00042	0.00048	CcSEcCtD
Cidofovir—Shock—Docetaxel—ovarian cancer	0.00042	0.00048	CcSEcCtD
Cidofovir—Nervous system disorder—Docetaxel—ovarian cancer	0.000418	0.000478	CcSEcCtD
Cidofovir—Thrombocytopenia—Docetaxel—ovarian cancer	0.000418	0.000477	CcSEcCtD
Cidofovir—Tachycardia—Docetaxel—ovarian cancer	0.000416	0.000476	CcSEcCtD
Cidofovir—Feeling abnormal—Paclitaxel—ovarian cancer	0.000415	0.000474	CcSEcCtD
Cidofovir—Skin disorder—Docetaxel—ovarian cancer	0.000414	0.000473	CcSEcCtD
Cidofovir—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000414	0.000473	CcSEcCtD
Cidofovir—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000412	0.00047	CcSEcCtD
Cidofovir—Renal failure—Doxorubicin—ovarian cancer	0.00041	0.000469	CcSEcCtD
Cidofovir—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000409	0.000468	CcSEcCtD
Cidofovir—Jaundice—Doxorubicin—ovarian cancer	0.000407	0.000465	CcSEcCtD
Cidofovir—Stomatitis—Doxorubicin—ovarian cancer	0.000407	0.000465	CcSEcCtD
Cidofovir—Anorexia—Docetaxel—ovarian cancer	0.000407	0.000465	CcSEcCtD
Cidofovir—Rhinitis—Epirubicin—ovarian cancer	0.000406	0.000464	CcSEcCtD
Cidofovir—Conjunctivitis—Doxorubicin—ovarian cancer	0.000406	0.000464	CcSEcCtD
Cidofovir—Urinary tract infection—Doxorubicin—ovarian cancer	0.000406	0.000464	CcSEcCtD
Cidofovir—Hepatitis—Epirubicin—ovarian cancer	0.000405	0.000463	CcSEcCtD
Cidofovir—Pharyngitis—Epirubicin—ovarian cancer	0.000402	0.000459	CcSEcCtD
Cidofovir—Sweating—Doxorubicin—ovarian cancer	0.0004	0.000457	CcSEcCtD
Cidofovir—Urinary tract disorder—Epirubicin—ovarian cancer	0.0004	0.000457	CcSEcCtD
Cidofovir—Urticaria—Paclitaxel—ovarian cancer	0.0004	0.000457	CcSEcCtD
Cidofovir—Oedema peripheral—Epirubicin—ovarian cancer	0.000399	0.000456	CcSEcCtD
Cidofovir—Hypotension—Docetaxel—ovarian cancer	0.000399	0.000455	CcSEcCtD
Cidofovir—Haematuria—Doxorubicin—ovarian cancer	0.000398	0.000455	CcSEcCtD
Cidofovir—Abdominal pain—Paclitaxel—ovarian cancer	0.000398	0.000455	CcSEcCtD
Cidofovir—Body temperature increased—Paclitaxel—ovarian cancer	0.000398	0.000455	CcSEcCtD
Cidofovir—Urethral disorder—Epirubicin—ovarian cancer	0.000397	0.000454	CcSEcCtD
Cidofovir—Epistaxis—Doxorubicin—ovarian cancer	0.000394	0.00045	CcSEcCtD
Cidofovir—Sinusitis—Doxorubicin—ovarian cancer	0.000392	0.000447	CcSEcCtD
Cidofovir—Visual impairment—Epirubicin—ovarian cancer	0.00039	0.000446	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000389	0.000444	CcSEcCtD
Cidofovir—Insomnia—Docetaxel—ovarian cancer	0.000386	0.000441	CcSEcCtD
Cidofovir—Paraesthesia—Docetaxel—ovarian cancer	0.000383	0.000438	CcSEcCtD
Cidofovir—Erythema multiforme—Epirubicin—ovarian cancer	0.000383	0.000438	CcSEcCtD
Cidofovir—Dyspnoea—Docetaxel—ovarian cancer	0.00038	0.000435	CcSEcCtD
Cidofovir—Somnolence—Docetaxel—ovarian cancer	0.000379	0.000433	CcSEcCtD
Cidofovir—Eye disorder—Epirubicin—ovarian cancer	0.000379	0.000432	CcSEcCtD
Cidofovir—Tinnitus—Epirubicin—ovarian cancer	0.000378	0.000431	CcSEcCtD
Cidofovir—Flushing—Epirubicin—ovarian cancer	0.000376	0.000429	CcSEcCtD
Cidofovir—Rhinitis—Doxorubicin—ovarian cancer	0.000376	0.000429	CcSEcCtD
Cidofovir—Dyspepsia—Docetaxel—ovarian cancer	0.000376	0.000429	CcSEcCtD
Cidofovir—Hepatitis—Doxorubicin—ovarian cancer	0.000375	0.000428	CcSEcCtD
Cidofovir—Pharyngitis—Doxorubicin—ovarian cancer	0.000372	0.000425	CcSEcCtD
Cidofovir—Decreased appetite—Docetaxel—ovarian cancer	0.000371	0.000424	CcSEcCtD
Cidofovir—Hypersensitivity—Paclitaxel—ovarian cancer	0.000371	0.000424	CcSEcCtD
Cidofovir—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00037	0.000423	CcSEcCtD
Cidofovir—Oedema peripheral—Doxorubicin—ovarian cancer	0.000369	0.000422	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000368	0.000421	CcSEcCtD
Cidofovir—Angiopathy—Epirubicin—ovarian cancer	0.000367	0.00042	CcSEcCtD
Cidofovir—Urethral disorder—Doxorubicin—ovarian cancer	0.000367	0.00042	CcSEcCtD
Cidofovir—Mediastinal disorder—Epirubicin—ovarian cancer	0.000365	0.000417	CcSEcCtD
Cidofovir—Pain—Docetaxel—ovarian cancer	0.000365	0.000417	CcSEcCtD
Cidofovir—Constipation—Docetaxel—ovarian cancer	0.000365	0.000417	CcSEcCtD
Cidofovir—Chills—Epirubicin—ovarian cancer	0.000363	0.000415	CcSEcCtD
Cidofovir—Visual impairment—Doxorubicin—ovarian cancer	0.000361	0.000413	CcSEcCtD
Cidofovir—Asthenia—Paclitaxel—ovarian cancer	0.000361	0.000413	CcSEcCtD
Cidofovir—Alopecia—Epirubicin—ovarian cancer	0.000358	0.000409	CcSEcCtD
Cidofovir—Pruritus—Paclitaxel—ovarian cancer	0.000356	0.000407	CcSEcCtD
Cidofovir—Erythema multiforme—Doxorubicin—ovarian cancer	0.000354	0.000405	CcSEcCtD
Cidofovir—Feeling abnormal—Docetaxel—ovarian cancer	0.000352	0.000402	CcSEcCtD
Cidofovir—Eye disorder—Doxorubicin—ovarian cancer	0.00035	0.0004	CcSEcCtD
Cidofovir—Tinnitus—Doxorubicin—ovarian cancer	0.000349	0.000399	CcSEcCtD
Cidofovir—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000349	0.000399	CcSEcCtD
Cidofovir—Flushing—Doxorubicin—ovarian cancer	0.000348	0.000397	CcSEcCtD
Cidofovir—Flatulence—Epirubicin—ovarian cancer	0.000347	0.000397	CcSEcCtD
Cidofovir—Tension—Epirubicin—ovarian cancer	0.000346	0.000395	CcSEcCtD
Cidofovir—Dysgeusia—Epirubicin—ovarian cancer	0.000345	0.000394	CcSEcCtD
Cidofovir—Diarrhoea—Paclitaxel—ovarian cancer	0.000344	0.000393	CcSEcCtD
Cidofovir—Nervousness—Epirubicin—ovarian cancer	0.000342	0.000391	CcSEcCtD
Cidofovir—Back pain—Epirubicin—ovarian cancer	0.000341	0.00039	CcSEcCtD
Cidofovir—Angiopathy—Doxorubicin—ovarian cancer	0.00034	0.000388	CcSEcCtD
Cidofovir—Muscle spasms—Epirubicin—ovarian cancer	0.000339	0.000387	CcSEcCtD
Cidofovir—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000338	0.000386	CcSEcCtD
Cidofovir—Body temperature increased—Docetaxel—ovarian cancer	0.000337	0.000385	CcSEcCtD
Cidofovir—Abdominal pain—Docetaxel—ovarian cancer	0.000337	0.000385	CcSEcCtD
Cidofovir—Chills—Doxorubicin—ovarian cancer	0.000336	0.000384	CcSEcCtD
Cidofovir—Dizziness—Paclitaxel—ovarian cancer	0.000333	0.00038	CcSEcCtD
Cidofovir—Alopecia—Doxorubicin—ovarian cancer	0.000331	0.000378	CcSEcCtD
Cidofovir—Ill-defined disorder—Epirubicin—ovarian cancer	0.000327	0.000374	CcSEcCtD
Cidofovir—Anaemia—Epirubicin—ovarian cancer	0.000326	0.000372	CcSEcCtD
Cidofovir—Agitation—Epirubicin—ovarian cancer	0.000324	0.00037	CcSEcCtD
Cidofovir—Flatulence—Doxorubicin—ovarian cancer	0.000321	0.000367	CcSEcCtD
Cidofovir—Tension—Doxorubicin—ovarian cancer	0.00032	0.000366	CcSEcCtD
Cidofovir—Vomiting—Paclitaxel—ovarian cancer	0.00032	0.000366	CcSEcCtD
Cidofovir—Dysgeusia—Doxorubicin—ovarian cancer	0.000319	0.000365	CcSEcCtD
Cidofovir—Malaise—Epirubicin—ovarian cancer	0.000318	0.000363	CcSEcCtD
Cidofovir—Rash—Paclitaxel—ovarian cancer	0.000317	0.000363	CcSEcCtD
Cidofovir—Dermatitis—Paclitaxel—ovarian cancer	0.000317	0.000362	CcSEcCtD
Cidofovir—Nervousness—Doxorubicin—ovarian cancer	0.000317	0.000362	CcSEcCtD
Cidofovir—Vertigo—Epirubicin—ovarian cancer	0.000317	0.000362	CcSEcCtD
Cidofovir—Syncope—Epirubicin—ovarian cancer	0.000316	0.000361	CcSEcCtD
Cidofovir—Leukopenia—Epirubicin—ovarian cancer	0.000316	0.000361	CcSEcCtD
Cidofovir—Back pain—Doxorubicin—ovarian cancer	0.000316	0.000361	CcSEcCtD
Cidofovir—Headache—Paclitaxel—ovarian cancer	0.000315	0.00036	CcSEcCtD
Cidofovir—Hypersensitivity—Docetaxel—ovarian cancer	0.000314	0.000359	CcSEcCtD
Cidofovir—Muscle spasms—Doxorubicin—ovarian cancer	0.000314	0.000358	CcSEcCtD
Cidofovir—Loss of consciousness—Epirubicin—ovarian cancer	0.00031	0.000354	CcSEcCtD
Cidofovir—Cough—Epirubicin—ovarian cancer	0.000308	0.000352	CcSEcCtD
Cidofovir—Asthenia—Docetaxel—ovarian cancer	0.000306	0.00035	CcSEcCtD
Cidofovir—Convulsion—Epirubicin—ovarian cancer	0.000305	0.000349	CcSEcCtD
Cidofovir—Hypertension—Epirubicin—ovarian cancer	0.000304	0.000348	CcSEcCtD
Cidofovir—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000303	0.000346	CcSEcCtD
Cidofovir—Pruritus—Docetaxel—ovarian cancer	0.000302	0.000345	CcSEcCtD
Cidofovir—Anaemia—Doxorubicin—ovarian cancer	0.000302	0.000344	CcSEcCtD
Cidofovir—Arthralgia—Epirubicin—ovarian cancer	0.0003	0.000343	CcSEcCtD
Cidofovir—Chest pain—Epirubicin—ovarian cancer	0.0003	0.000343	CcSEcCtD
Cidofovir—Myalgia—Epirubicin—ovarian cancer	0.0003	0.000343	CcSEcCtD
Cidofovir—Agitation—Doxorubicin—ovarian cancer	0.0003	0.000343	CcSEcCtD
Cidofovir—Anxiety—Epirubicin—ovarian cancer	0.000299	0.000342	CcSEcCtD
Cidofovir—Nausea—Paclitaxel—ovarian cancer	0.000299	0.000342	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000298	0.000341	CcSEcCtD
Cidofovir—Discomfort—Epirubicin—ovarian cancer	0.000297	0.000339	CcSEcCtD
Cidofovir—Malaise—Doxorubicin—ovarian cancer	0.000294	0.000336	CcSEcCtD
Cidofovir—Dry mouth—Epirubicin—ovarian cancer	0.000294	0.000335	CcSEcCtD
Cidofovir—Vertigo—Doxorubicin—ovarian cancer	0.000293	0.000335	CcSEcCtD
Cidofovir—Syncope—Doxorubicin—ovarian cancer	0.000293	0.000334	CcSEcCtD
Cidofovir—Leukopenia—Doxorubicin—ovarian cancer	0.000292	0.000334	CcSEcCtD
Cidofovir—Diarrhoea—Docetaxel—ovarian cancer	0.000292	0.000333	CcSEcCtD
Cidofovir—Confusional state—Epirubicin—ovarian cancer	0.00029	0.000331	CcSEcCtD
Cidofovir—Anaphylactic shock—Epirubicin—ovarian cancer	0.000288	0.000329	CcSEcCtD
Cidofovir—Oedema—Epirubicin—ovarian cancer	0.000288	0.000329	CcSEcCtD
Cidofovir—Loss of consciousness—Doxorubicin—ovarian cancer	0.000287	0.000328	CcSEcCtD
Cidofovir—Infection—Epirubicin—ovarian cancer	0.000286	0.000327	CcSEcCtD
Cidofovir—Cough—Doxorubicin—ovarian cancer	0.000285	0.000325	CcSEcCtD
Cidofovir—Shock—Epirubicin—ovarian cancer	0.000283	0.000323	CcSEcCtD
Cidofovir—Convulsion—Doxorubicin—ovarian cancer	0.000283	0.000323	CcSEcCtD
Cidofovir—Nervous system disorder—Epirubicin—ovarian cancer	0.000282	0.000322	CcSEcCtD
Cidofovir—Dizziness—Docetaxel—ovarian cancer	0.000282	0.000322	CcSEcCtD
Cidofovir—Thrombocytopenia—Epirubicin—ovarian cancer	0.000282	0.000322	CcSEcCtD
Cidofovir—Hypertension—Doxorubicin—ovarian cancer	0.000282	0.000322	CcSEcCtD
Cidofovir—Tachycardia—Epirubicin—ovarian cancer	0.000281	0.000321	CcSEcCtD
Cidofovir—Skin disorder—Epirubicin—ovarian cancer	0.00028	0.000319	CcSEcCtD
Cidofovir—Hyperhidrosis—Epirubicin—ovarian cancer	0.000278	0.000318	CcSEcCtD
Cidofovir—Myalgia—Doxorubicin—ovarian cancer	0.000278	0.000317	CcSEcCtD
Cidofovir—Arthralgia—Doxorubicin—ovarian cancer	0.000278	0.000317	CcSEcCtD
Cidofovir—Chest pain—Doxorubicin—ovarian cancer	0.000278	0.000317	CcSEcCtD
Cidofovir—Anxiety—Doxorubicin—ovarian cancer	0.000277	0.000316	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000276	0.000315	CcSEcCtD
Cidofovir—Discomfort—Doxorubicin—ovarian cancer	0.000274	0.000314	CcSEcCtD
Cidofovir—Anorexia—Epirubicin—ovarian cancer	0.000274	0.000313	CcSEcCtD
Cidofovir—Dry mouth—Doxorubicin—ovarian cancer	0.000272	0.00031	CcSEcCtD
Cidofovir—Vomiting—Docetaxel—ovarian cancer	0.000271	0.00031	CcSEcCtD
Cidofovir—Rash—Docetaxel—ovarian cancer	0.000269	0.000307	CcSEcCtD
Cidofovir—Hypotension—Epirubicin—ovarian cancer	0.000269	0.000307	CcSEcCtD
Cidofovir—Dermatitis—Docetaxel—ovarian cancer	0.000269	0.000307	CcSEcCtD
Cidofovir—Confusional state—Doxorubicin—ovarian cancer	0.000268	0.000307	CcSEcCtD
Cidofovir—Headache—Docetaxel—ovarian cancer	0.000267	0.000305	CcSEcCtD
Cidofovir—Oedema—Doxorubicin—ovarian cancer	0.000266	0.000304	CcSEcCtD
Cidofovir—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000266	0.000304	CcSEcCtD
Cidofovir—Infection—Doxorubicin—ovarian cancer	0.000265	0.000302	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000262	0.0003	CcSEcCtD
Cidofovir—Shock—Doxorubicin—ovarian cancer	0.000262	0.000299	CcSEcCtD
Cidofovir—Nervous system disorder—Doxorubicin—ovarian cancer	0.000261	0.000298	CcSEcCtD
Cidofovir—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000261	0.000298	CcSEcCtD
Cidofovir—Insomnia—Epirubicin—ovarian cancer	0.00026	0.000297	CcSEcCtD
Cidofovir—Tachycardia—Doxorubicin—ovarian cancer	0.00026	0.000297	CcSEcCtD
Cidofovir—Skin disorder—Doxorubicin—ovarian cancer	0.000259	0.000295	CcSEcCtD
Cidofovir—Paraesthesia—Epirubicin—ovarian cancer	0.000258	0.000295	CcSEcCtD
Cidofovir—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000257	0.000294	CcSEcCtD
Cidofovir—Dyspnoea—Epirubicin—ovarian cancer	0.000257	0.000293	CcSEcCtD
Cidofovir—Somnolence—Epirubicin—ovarian cancer	0.000256	0.000292	CcSEcCtD
Cidofovir—Anorexia—Doxorubicin—ovarian cancer	0.000254	0.00029	CcSEcCtD
Cidofovir—Nausea—Docetaxel—ovarian cancer	0.000253	0.00029	CcSEcCtD
Cidofovir—Dyspepsia—Epirubicin—ovarian cancer	0.000253	0.000289	CcSEcCtD
Cidofovir—Decreased appetite—Epirubicin—ovarian cancer	0.00025	0.000286	CcSEcCtD
Cidofovir—Hypotension—Doxorubicin—ovarian cancer	0.000249	0.000284	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000248	0.000284	CcSEcCtD
Cidofovir—Pain—Epirubicin—ovarian cancer	0.000246	0.000281	CcSEcCtD
Cidofovir—Constipation—Epirubicin—ovarian cancer	0.000246	0.000281	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000243	0.000277	CcSEcCtD
Cidofovir—Insomnia—Doxorubicin—ovarian cancer	0.000241	0.000275	CcSEcCtD
Cidofovir—Paraesthesia—Doxorubicin—ovarian cancer	0.000239	0.000273	CcSEcCtD
Cidofovir—Dyspnoea—Doxorubicin—ovarian cancer	0.000237	0.000271	CcSEcCtD
Cidofovir—Feeling abnormal—Epirubicin—ovarian cancer	0.000237	0.000271	CcSEcCtD
Cidofovir—Somnolence—Doxorubicin—ovarian cancer	0.000237	0.00027	CcSEcCtD
Cidofovir—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000235	0.000269	CcSEcCtD
Cidofovir—Dyspepsia—Doxorubicin—ovarian cancer	0.000234	0.000268	CcSEcCtD
Cidofovir—Decreased appetite—Doxorubicin—ovarian cancer	0.000231	0.000264	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00023	0.000263	CcSEcCtD
Cidofovir—Urticaria—Epirubicin—ovarian cancer	0.000229	0.000261	CcSEcCtD
Cidofovir—Pain—Doxorubicin—ovarian cancer	0.000228	0.00026	CcSEcCtD
Cidofovir—Constipation—Doxorubicin—ovarian cancer	0.000228	0.00026	CcSEcCtD
Cidofovir—Body temperature increased—Epirubicin—ovarian cancer	0.000227	0.00026	CcSEcCtD
Cidofovir—Abdominal pain—Epirubicin—ovarian cancer	0.000227	0.00026	CcSEcCtD
Cidofovir—Feeling abnormal—Doxorubicin—ovarian cancer	0.000219	0.000251	CcSEcCtD
Cidofovir—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000218	0.000249	CcSEcCtD
Cidofovir—Hypersensitivity—Epirubicin—ovarian cancer	0.000212	0.000242	CcSEcCtD
Cidofovir—Urticaria—Doxorubicin—ovarian cancer	0.000212	0.000242	CcSEcCtD
Cidofovir—Abdominal pain—Doxorubicin—ovarian cancer	0.00021	0.00024	CcSEcCtD
Cidofovir—Body temperature increased—Doxorubicin—ovarian cancer	0.00021	0.00024	CcSEcCtD
Cidofovir—Asthenia—Epirubicin—ovarian cancer	0.000206	0.000236	CcSEcCtD
Cidofovir—Pruritus—Epirubicin—ovarian cancer	0.000204	0.000233	CcSEcCtD
Cidofovir—Diarrhoea—Epirubicin—ovarian cancer	0.000197	0.000225	CcSEcCtD
Cidofovir—Hypersensitivity—Doxorubicin—ovarian cancer	0.000196	0.000224	CcSEcCtD
Cidofovir—Asthenia—Doxorubicin—ovarian cancer	0.000191	0.000218	CcSEcCtD
Cidofovir—Dizziness—Epirubicin—ovarian cancer	0.00019	0.000217	CcSEcCtD
Cidofovir—Pruritus—Doxorubicin—ovarian cancer	0.000188	0.000215	CcSEcCtD
Cidofovir—Vomiting—Epirubicin—ovarian cancer	0.000183	0.000209	CcSEcCtD
Cidofovir—Diarrhoea—Doxorubicin—ovarian cancer	0.000182	0.000208	CcSEcCtD
Cidofovir—Rash—Epirubicin—ovarian cancer	0.000181	0.000207	CcSEcCtD
Cidofovir—Dermatitis—Epirubicin—ovarian cancer	0.000181	0.000207	CcSEcCtD
Cidofovir—Headache—Epirubicin—ovarian cancer	0.00018	0.000206	CcSEcCtD
Cidofovir—Dizziness—Doxorubicin—ovarian cancer	0.000176	0.000201	CcSEcCtD
Cidofovir—Nausea—Epirubicin—ovarian cancer	0.000171	0.000195	CcSEcCtD
Cidofovir—Vomiting—Doxorubicin—ovarian cancer	0.000169	0.000193	CcSEcCtD
Cidofovir—Rash—Doxorubicin—ovarian cancer	0.000168	0.000192	CcSEcCtD
Cidofovir—Dermatitis—Doxorubicin—ovarian cancer	0.000168	0.000192	CcSEcCtD
Cidofovir—Headache—Doxorubicin—ovarian cancer	0.000167	0.000191	CcSEcCtD
Cidofovir—Nausea—Doxorubicin—ovarian cancer	0.000158	0.000181	CcSEcCtD
